To our knowledge, no systematic reviews or meta-analyses have been conducted to assess the effectiveness of preventive psychological and/or educational interventions for anxiety in varied populations.
T he annual prevalence of anxiety disorders is 6.7% in the general population. 1 The burden of disease in terms of years lived with disability attributable to anxiety disorders increased by 14.8% (relative increase) between 2005 and 2015, ranking ninth in the world and eighth in high-income countries.
2 Among mental and substance use disorders, anxiety ranked second in the world. 3 Although there are effective treatments for anxiety disorders, 4-6 not all persons with anxiety receive the appropriate treatment, 7 and cost-effectiveness studies suggest that treatment alone is not sufficient to eliminate the disease burden attributable to anxiety disorders. 8 An additional way to reduce the burden of anxiety disorders is to lower the incidence of new cases, which can be achieved through prevention rather than treatment. Previous systematic reviews or meta-analyses of the prevention of anxiety have been mainly undertaken in children and/or adolescents. [9] [10] [11] [12] [13] In adults, studies have traditionally focused on specific anxiety disorders, such as posttraumatic stress disorder. 14, 15 One meta-analysis 16 assessed the prevention of anxiety in the general population, although it was centered on specific cognitive-behavioral interventions. To the best of our knowledge, no systematic review or meta-analysis has been performed on the effectiveness of psychological and/or educational interventions in preventing anxiety in several types of populations. The aim of the present systematic review and meta-analysis was to evaluate the effectiveness of psychological and/or educational interventions in preventing anxiety in varied populations.
Methods
We followed PRISMA guidelines for reporting systematic reviews and meta-analyses. 17 The protocol of this systematic review was previously registered at the International Prospective Register of Systematic Reviews. The Institute of Biomedical Research in Málaga, Málaga, Spain, approved the study.
Search Strategies
We systematically searched 6 electronic databases, including PubMed, PsycINFO, EMBASE, Web of Science, OpenGrey (System for Information on Grey Literature in Europe), and CENTRAL (Cochrane Central Register of Controlled Trials) from inception to March 7, 2017 . No date or language restrictions were imposed. This search strategy was complemented with hand searching of reference lists in articles and other reviews on this topic. In addition, experts in the field were contacted and asked to complete the list of selected publications. Databases were searched separately by 2 of us (P.M.-P. and S.C.-C.). The specific search strategies used are described in the eAppendix in the Supplement.
Eligibility Criteria
We selected randomized clinical trials (RCTs) because they are the standard for clinical trials. 18 We focused on educational and/or psychological interventions. The former simply provide information about anxiety through lectures or fact sheets, whereas psychological interventions attempt to change how people think by using a variety of strategies (eg, cognitive behavioral or interpersonal therapy). Randomized clinical trials based on medication or physical interventions (eg, sports) were excluded. The comparators allowed were care-as-usual, no intervention, a waiting list for intervention, or attention control. To separate the effectiveness of prevention from that of therapies, baseline anxiety was required to have been discarded through standardized interviews (eg, Structured Clinical Interview for DSM Disorders), validated self-reports with standard cutoff points (eg, Beck Anxiety Inventory-II), or diagnosis by a mental health specialist. Outcomes included the incidence of new cases of any DSM-IV anxiety disorder and/or the reduction of anxiety symptoms. Outcomes were required to have been measured by standardized interviews or validated symptom scales. Posttraumatic stress disorder was excluded because, in this case, it is difficult to separate treatment from prevention. 19 Participants could have any demographic characteristic (eg, age, sex) , and all settings and languages were considered.
Selection of Studies
Titles and abstracts were reviewed independently by 2 of us (P.M.-P. and S.C.-C.), who used the abovementioned criteria to determine study eligibility. The full text of potentially relevant studies was reviewed for final inclusion. All discrepancies were resolved by consensus with 1 of us (M.R.-V. or A.F.). The degree of agreement between the initial reviewers was good (Cohen κ = 0.74; 95% CI, 0.60-0.89).
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Data Extraction
Data extracted from each study were recorded in an evidence table. Two of us (P.M.-P. and S.C.-C.) collected data from primary studies. Any discrepancies were solved by consensus between the reviewers. When necessary information was not reported in the study, the authors of the original article were contacted for further details.
by 2 of us (P.M.-P. and S.C.-C.). The level of agreement was good (intraclass correlation coefficient, 0.83; 95% CI, 0.77-0.87).
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Statistical Analysis
When the outcome was differences in anxiety symptoms between intervention and control groups, means (SDs) for each arm were extracted. We then calculated standardized mean differences (SMDs) for each RCT by estimating the mean SMD at different follow-up times. The pooled SMDs for all RCTs and their 95% CIs were estimated. Negative SMDs represented an improvement in the reduction of anxiety symptoms in the intervention group. If only new cases of anxiety were reported (incidence of anxiety), CMA, version 3.0 (Comprehensive Metaanalysis Software Biostat Inc) was used to obtain the equivalent SMDs. Cohen 23 suggested that an SMD of 0.2 is indicating a low effect; 0.5, a moderate effect; and 0.8, a large effect. We inflated the SEs of the nested comparisons in the same RCT following the suggestions of Cates. 24 We selected the randomeffects model for the study under the assumption that the studies included in the meta-analysis were performed in a variety of populations that may differ from each other.
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Statistical heterogeneity was evaluated using the I 2 statistic, in which a value of 0% to 40% might indicate no important heterogeneity; 30% to 60%, moderate; 50% to 90%, substantial; and 75% to 100%, considerable. 21 In addition, we calculated the Q statistic and its P value. To detect publication bias, a funnel plot was examined by visual inspection and the Duval and Tweedie 25 trim-and-fill procedure, which is a test of symmetry of the funnel plot. This procedure yields an adjusted pooled effect size after accounting for missing studies due to publication bias. We also performed Begg and Mazumdar rank correlation 26 and the Egger test.
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Since the SMD could differ at varying follow-up times, we also conducted sensitivity analyses at first and last followups. Sensitivity analyses also included fixed effects and Hedges g and excluded some RCTs from analysis (those that caused the greatest increase in heterogeneity and those that measured anxiety as a secondary outcome).
We used a mixed-effects model for subgroup analyses according to the type of prevention, type of outcome measure (symptoms scale vs standardized diagnostic interview), type of anxiety, country, population age, setting, comparator, professional delivering the intervention, intervention orientation, type of intervention, intervention format, number of sessions, follow-up, sample size, and risk of bias.
Meta-regression was performed to explain the betweentrial heterogeneity observed. We verified normality of the quantitative variables that were included in the meta-regression by the skewness-kurtosis normality test, 28 performing the pertinent transformations to get approximation to normality when it was necessary. We forced 2 quantitative variables-risk of bias and sample size-in the meta-regression models for adjustment. The former is related to the quality of the RCTs and the latter to publication bias. Of the remaining covariables considered for subgroup analysis, only 1 covariable was introduced in each new model. 
Results
Search Results
A total of 3273 abstracts were reviewed. Of these, 131 articles were included for full-text review, and 29 RCTs met the inclusion criteria of the meta-analysis (Figure 1 ).
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Characteristics of Included Studies
The characteristics of the 29 RCTs included are described in eTable 1 in the Supplement. Twenty studies were published in or after 2010, and only 3 RCTs were published before 2005. Seven RCTs were conducted in the United States. A total of 10 430 patients were enrolled. Sample sizes ranged from 24 to 2998 (median, 165) . A total of 9 RCTs included adults (from 18 to 65 years), 9 included children or adolescents, 4 were performed in older adults, 6 in adults and elderly individuals, and 1 in both adults and children. Settings included school or university in 12 RCTs. Interventions were based on the principle of cognitive behavioral therapy in 25 RCTs, whereas 4 RCTs were based on other types of interventions (2 psychoeducational, 1 acceptance and commitment therapy, and 1 biopsychosocial). Interventions were delivered in individual format in 14 RCTs. Four RCTs included interventions with a guided self-help format (computerized). The number of sessions ranged from 1 to 12 (median, 8). The comparator used was care-as-usual in 13 RCTs. Interventions were conducted by a mental health specialist in 13 RCTs.
Follow-up periods ranged from 7 weeks to 60 months (median, 12 months). The duration of follow-up exceeded 12 months in 8 RCTs.
Indicated, selective, and universal prevention were evaluated in 11, 10, and 8 RCTs, respectively. With respect to outcomes, 10 RCTs measured the reduction in anxiety symptoms and 10 determined the incidence of anxiety disorders; 9 RCTs measured both reduction of symptoms and incidence.
Risk of Bias in Included Studies
The risk of bias for each study is reported in eTable 2 in the Supplement. Eight RCTs had a low risk (≤4 points), 9 had a moderate risk (5-6 points), and 12 had a high risk (≥7 points) of bias.
Effectiveness of the Interventions to Prevent Anxiety
Meta-analysis calculations were based on 36 comparisons performed in 29 RCTs (eTable 3 in the Supplement). The pooled SMD was −0.31 (95% CI, −0.40 to −0.21; P < .001), and the equivalent pooled odds ratio (OR) was 0.57 (95% CI, 0.48 to 0.68; P < .001)-a 43% reduction in the incidence of anxiety-with substantial heterogeneity (I 2 = 61.1%;
Q 35 = 90.13; P < .001). This finding means that psychological and/or educational preventive interventions for anxiety had a small and statistically significant effect on anxiety prevention. Figure 2 shows the forest plot for the overall and individual effect sizes. 
Publication Bias
Results of the Egger (intercept, −1.30; 95% CI, −2.25 to −0.34; P = .01) and Begg and Mazumdar (z = −2.40; P = .02) tests indicated the presence of publication bias. The SMDs adjusted for publication bias according to the Duval and Tweedie trimand-fill procedure barely decreased (SMD, −0.27; 95% CI, −0.37 to −0.17; P < .001). The funnel plot is shown in eFigure 1 in the Supplement.
Sensitivity and Subgroup Analyses
Sensitivity analyses are reported in Subgroup analyses revealed differences in the effectiveness of psychological and/or educational interventions depending on the outcome measure, comparator, provider, sample size, risk of bias, and follow-up (eTable 4 in the Supplement).
Meta-regression
Meta-regression is reported in Table 2 . The skewnesskurtosis normality test was not statistically significant for logarithmic transformation of the sample size (χ 2 2 = 4.11; P = .13) and risk of bias (χ 2 2 = 1.99; P = .37) variables. As many as 85.3% of total variance was attributable to within-study variability, and the remaining 14.7% was attributable to between-study variability. In total, 99.6% of between-study variance was explained by the 5 variables included in the meta-regression model (F 5,30 = 9.31; P < .001). There was a statistically significant association between higher SMD when the comparator was waiting list (comparator) (β = −0.33 [95% CI, −0.55 to −0.11]; P = .005) and a lower sample size (lg) (β = 0.15 [95% CI, 0.06 to 0.23]; P = .001). There was no association between SMD and risk of bias, type of outcome measure (standardized interview), and family physician (caregiver). Analysis of residuals showed a good fit of the meta-regression model (eFigure 2 in the Supplement).
Discussion
We found that psychological and/or educational interventions are effective in the prevention of anxiety. The overall effect size was small but statistically significant. This result was derived from 29 RCTs (36 comparisons) that included 10 430 patients from 11 countries on 4 continents. Sensitivity analyses and adjustment for publication bias demonstrated that the overall effect size was robust. Heterogeneity was substantial and explained by a model of meta-regression including 5 variables, 2 of which had a statistically significant association with effect size (waiting list and sample size), whereas the other 3 variables did not (risk of bias, family physician as caregiver, and standardized interview as outcome).
Strengths
To the best of our knowledge, this is the first systematic review and meta-analysis to examine the effectiveness of psychological and/or educational interventions in the prevention of anxiety in varied types of populations. Our meta-analysis included a reasonable number of RCTs representing a large population of individuals with different characteristics and from diverse settings. In addition, this study involved a wide spectrum of interventions (any psychological and/or educational intervention) for most types of anxiety disorders (except posttraumatic stress disorder) and implemented by a variety of professionals in different settings. These aspects give the study a wide scope, which supports its external validity. We used multiple complementary electronic databases with supplementary hand searching. Thus, the variety of databases utilized, combined with the broad range of search terms, contributed to a highly sensitive search. In addition, the strict inclusion criteria, analyzing only RCTs with a study population free of anxiety at baseline, allowed us to distinguish prevention effectiveness from treatment effectiveness. Study selection, data extraction, and risk of bias assessment were performed by trained and independent reviewers, with good interobserver reliability. We performed sensitivity analyses and adjustment for publication bias, which support the robustness of the pooled SMDs. Finally, the meta-regression model explained heterogeneity and enabled adjustment for confounding biases and multiple comparisons.
Limitations
Our meta-analysis has several limitations. First, although most of the studies included had low to moderate risk of bias (17 RCTs), 12 had a high risk of bias. Subgroup analysis showed that the studies with a lower risk of bias had a tendency to report a smaller effect size (SMD, −0.15; 95% CI, −0.23 to −0.07) (eTable 4intheSupplement); nevertheless, after adjusting for confounding biases, the meta-regression model showed that the risk of bias was not significant. Second, the duration of follow-up exceeded 12 months in only 8 RCTs, which tended to report a lower effect size (SMD, 0.15; 95% CI, 0.01-0.29). Although follow-up duration was not significant when adjustment for sample size and risk of bias was performed, firm conclusions about long-term effectiveness cannot be drawn from our study. Third, the interventions implemented in most of the RCTs included in the meta-analysis were aimed at preventing more than 1 specific anxiety disorder or used nonspecific anxiety symptoms as outcomes; therefore, no inferences can be made about any specific anxiety disorder. Fourth, reduction of anxiety symptoms (measured by scales) was the only outcome of 10 RCTs; although the reliability and validity of scales are widely accepted, standardized diagnostic interviews generally have greater validity. Nevertheless, the reduction of anxiety symptoms is also useful as an outcome because it has a positive and relevant effect on quality of life and cost. 41, 61 Another related aspect is that RCTs in which standardized diagnostic interviews were conducted tended to report a lower effect size (SMD, −0.18; 95% CI, −0.30 to −0.06) (eTable 4 in the Supplement). Again, adjustment for confounding biases and multiple comparisons in meta-regression discarded any statistical significance. Fifth, evidence of publication bias was found, which means that it is likely that some RCTs with nonsignificant results have not been published. Nevertheless, this limitation does not seem relevant because the effect size scarcely decreased after adjustment for publication bias. Sixth, we cannot establish the superiority of one intervention over another (eg, cognitive behavioral therapy vs acceptance and commitment therapy) because it was not within the scope of the study and we excluded the few RCTs in which these types of comparisons were made. Seventh, it is probable that the effect size of the anxiety prevention that we obtained was smaller since it was increased by the use of waiting list comparator and small samples. Finally, in some categories in specific subgroup analysis, the number of RCTs or comparisons was low; in these cases (eg, type of anxiety), the lack of statistical power prevents firm conclusions.
Comparison With Existing Literature
The overall effect size obtained was small. Other metaanalyses on anxiety prevention report similar SMDs (range, 0.13-0.32), [11] [12] [13] 16 and the same occurs with meta-analyses on the prevention of depression.
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We found statistically significant associations only for sample size and waiting list as comparators when adjustment for confounding biases and multiplicity testing were performed in meta-regression. A recent meta-analysis on the effectiveness of cognitive behavioral therapy for anxiety disorders and major depression showed that responses were large when the control condition was waiting list but small to moderate when it was care-as-usual or pill placebo.
65 Similar results were found in a network meta-analysis on the effectiveness of treatments for depression. The authors suggest that waiting list can be a "nocebo" and may introduce negative psychological expectations in the sense of waiting for the desired active treatment, whereas patients allocated to nonintervention or usual care may more actively seek other treatments, either by themselves or by others, for their ailment. 66 In a recent meta-analysis, subgroup analysis of the prevention of anxiety in young people revealed that the studies in which waiting list was used as a comparator tended to report a significantly higher effect size; nevertheless, after adjustment for confounding factors in meta-regression, this tendency disappeared. 11 Zalta 16 found no statistically significant differences between active and nonactive comparators in a meta-analysis, although waiting list was categorized within the nonactive category and no adjustment for confounding factors was made. Regarding sample size, effect sizes were smaller in the RCTs with larger sample sizes after adjustment for confounding biases and multiple comparisons were performed. This effect could be due to publication bias, as evidenced in our meta-analysis, although its influence on the overall effect size was minimal. Studies with small samples are more likely to obtain negative results and not be published; however, when they yield statistically significant results, their effect sizes are higher.
Effect size tended to decrease when the outcomes were assessed using standardized diagnostic interviews, although no statistically significant associations were found in metaregression. When RCTs had small samples, they were more likely to determine statistically significant effects on anxiety prevention if symptom scales (difference of means) were utilized compared with structured interviews (comparison of proportions). Furthermore, there was a negative correlation between risk of bias and standardized interview as outcomes (ρ = −0.27). Therefore, the loss of statistical significance between effect size and standardized interview can be explained in part by adjustment for confounding factors with the introduction of the variables sample size and risk of bias in the meta-regression model. Adjustment for multiple comparisons also contributed to the loss of significance.
Regarding the professional who delivered the intervention (caregiver), effect sizes tended to increase when the caregiver was a family physician, but this effect was attenuated after adjustments in meta-regression. The SMDs for family physician and mental health specialist were similar, but the latter was removed from meta-regression because of collinearity. Nevertheless, interventions were led by a family physician in only 2 RCTs and results should therefore be interpreted with caution.
Subgroup analysis revealed statistically significant associations between low risk of bias with a lower effect size and follow-up time (SMDs higher in RCTs <6 months). However, this effect disappeared when adjustment for confounding bias was performed. No relevant differences were observed when the first (SMD, 0.30) and last (SMD, 0.33) evaluations were included as outcomes for sensitivity analysis. Other metaanalyses assessing studies on anxiety and depression 11, 16, 62, 63 report that effect size seems to diminish over time. Yet, a recent meta-analysis of studies on the prevention of depression found no association between effect size and follow-up time. 64 Regarding the risk of bias, a previous meta-analysis did not find any statistically significant association between risk of bias and effect size.
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A tendency was observed for SMDs to be higher in selective prevention, followed by indicated and universal prevention, although differences were not statistically significant even when adjustment for confounding bias was not performed. Some previous meta-analyses have not found any association between type of prevention and effect size 11, 12, 16 ;ho wever, 1 meta-analysis found that selective and indicated interventions had a greater effect size than universal prevention, 13 whereas another meta-analysis reported that universal prevention was more effective.
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As in the rest of the meta-analyses concerning the prevention of anxiety, [10] [11] [12] [13] 16 most of the interventions included in our study had a cognitive-behavioral orientation (31 comparisons; SMD, 0.25); the remaining 6 comparisons had other orientations and tended to have a greater response (SMD, 0.52), although it was not statistically significant. Therefore, no conclusions can be drawn about orientation.
Conclusions
The pooled effect size obtained for prevention of anxiety is modest compared with the sizes observed in treatments for anxiety disorders. 65 Although the preventive fraction that derived from the pooled effect size that we obtained (OR, 0.57)-43% reduction in the incidence of anxiety-was higher than those found in other meta-analyses, [11] [12] [13] [62] [63] [64] 
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Anxiety disorders are the most common mental disorders across the lifespan and exact a massive disease burden. 1 Anxiety disorders typically onset in childhood and predict a range of later mental health problems, such as depression, suicide, and substance abuse. Despite this, anxiety disorders are frequently underrecognized and overlooked as serious mental health problems. There are a number of factors that influence the limited attention anxiety disorders receive, both in terms of clinical practice and public health policy. The reduced focus is likely in part because of poor mental health literacy. There is a common misconception that anxiety disorders are reserved for the "worried well" and represent a personality flaw rather than a disorder. In addition, anxiety itself is a normal emotion, perhaps leading to misunderstanding surrounding the difference between normal and pathological fear and anxiety. The transient nature of some fears in early childhood may also lead to a misconception that the disorder will remit with time or maturation. For most individuals, anxiety disorders are relatively stable, long-term, and disabling and need to be taken seriously. 
CENTRAL:
("anxiety":ti,ab,kw or "anxiety disorder":ti,ab,kw) AND (health education:ti,ab,kw or psychoeducat*:ti,ab,kw or educat*:ti,ab,kw or psychol*:ti,ab,kw) AND (primary prevention:ti,ab,kw or prevent*:ti,ab,kw)
Embase:
('anxiety'/exp OR 'anxiety' OR 'anxiety disorder'/exp OR 'anxiety disorder') AND ('psychoeducation'/exp OR 'psychoeducat*' OR 'health education'/exp OR 'health education' OR 'psychol*' OR 'educat*' OR 'psychological techniques'/exp OR 'psychological techniques') AND ((primary AND prevention:ab,ti) OR (prevent*:ab,ti)) AND ('randomized controlled trial'/exp OR (random* AND controlled AND trial) OR ('controlled clinical trial'/exp OR 'controlled clinical trial'))
Web of Science:
TS= ((randomized controlled trial OR (random* AND controlled AND trial) OR controlled clinical trial)) AND TS= ((anxiety disorders OR (anxiety AND disorders) OR anxiety)) AND TS= ((prevent* OR primary prevention)) AND TS= ((Health Education OR psychoeducat* OR educat* OR psychol* OR psychological techniques))
PsycINFO:
((anxiety OR anxiety disorders OR (anxiety AND disorder)) AND (health education OR psychoeducat* OR educat* OR psychol* OR psychological techniques)) AND ab(((primary prevention OR prevent*))) AND ((randomized controlled trials OR (random* AND controlled AND trial) OR controlled clinical trial))
OpenGrey:
(anxiety) AND (prevent*) AND (Health Education OR psychoeducat* OR educat* OR psychol*) 2) "Activity-scheduling": a module of "Coping With Depression"; Guided selfhelp course (individual).
3) Life review and consultation with the general practitioner (individual). 
